Illumina

Staff Medical Science Liaison - West Coast U.S.

United States

Illumina Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Genomics, Medical DevicesIndustries

Requirements

Candidates should demonstrate a comprehensive understanding of Illumina, its product offerings, recent medical and scientific advancements, and key publications in the field of precision medicine, with a focus on oncology. They should be able to provide impactful medical education presentations across diverse oncology settings, including medical conferences, sessions for allied healthcare professionals, and formulary committees, while gathering actionable feedback for organizational sharing and improvement.

Responsibilities

The Staff Medical Science Liaison will be responsible for leading and executing the Medical Affairs Strategy in the US, providing medical leadership and expertise in planning, developing, and commercializing Illumina’s sequencing, assay, and software products for oncology. This includes developing and executing strategies for evidence generation, medical education, and managing relationships with key opinion leaders (KOLs), health care professionals (HCPs), health care organizations (HCOs), professional societies, and customers within the US to enable the adoption of Illumina’s products in the clinical market. They will work across Illumina’s cross-functional teams (Sales, Marketing, Markets Access, Government Affairs, Regulatory, and Clinical Affairs, etc.) to ensure alignment with corporate goals and objectives.

Skills

Medical Education
Scientific Knowledge
Oncology
Presentation Skills
Feedback Gathering
KOL Management
HCP Engagement
HCO Engagement
Medical Affairs Strategy
Evidence Generation

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI